Finzati - Logo
TBPH logo

Theravance Biopharma, Inc.

TBPH • Biotechnology
$17.08
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Solid company profile with reasonable valuation support. The data suggests a balanced quality/value setup.
Market Cap
$875.85M
Growth
11.5%
Cash Flow
1/5
Trend
Volatile
Evidence
Stable or improving margins · 98.5%Positive revenue growth · 28.0%Positive free cash flow · 4.74Reasonable earnings multiple · 8.89Manageable debt level · 0.25
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 7, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$17.08
Change0.00%
Shares Out51.28M
Market Cap$875.85M
Enterprise Value$524.73M
52W Range10.46 - 21.03
Beta0.17
P/E7.65
P/S7.98
P/B3.01
P/FCF3.26
EV/Sales4.78

Investment DNA

How strong this company looks for long-term investors

73
out of 100
Business Quality
Margins, moat, returns
65/100
Financial Strength
Debt, cash, stability
76/100
Growth Potential
Revenue and expansion
95/100
Price Attractiveness
Cheap or expensive today
74/100
Why this score▼
Stable or improving margins · 98.5%Positive revenue growth · 28.0%Positive free cash flow · 4.74Reasonable earnings multiple · 8.89Manageable debt level · 0.25Healthy liquidity · 10.93

Analyst view

Analyst sentiment and price target

TBPH
Analyst sentiment
Based on 17 analyst votes · 2026-09-05
53/100
Neutral
Bullish
4
Hold
10
Bearish
3
Price Target
2026-06-24
Low
$14.00
Mean
$14.00
Median
$14.00
High
$14.00

Company Overview

IPO: 5/16/2014
Industry: Biotechnology
P/B i: 3.01
Debt / Equity i: 0.25
Operating Margin: -12.33%
Net Margin: 98.54%
ROE i: -
ROIC: -

Financial Health

Score15 / 20
Debt / Equity: 0.25
Current Ratio: 10.93
Quick Ratio: 10.93
Status: Good

Insider Transactions

Recent executive and insider activity

Miller Aine
Transaction: 06/19/2026
BUY
Change
+18,750
Price
Not reported
Filing
06/23/2026
Type
BUY
Farnum Rhonda
Transaction: 06/15/2026
SELL
Change
-6,657
Price
$16.39
Filing
06/17/2026
Type
SELL
PAKIANATHAN DEEPIKA
Transaction: 06/12/2026
BUY
Change
+13,398
Price
$16.64
Filing
06/16/2026
Type
BUY